TrademarkDir
HYSEQ
DEAD

Serial Number

74384099

Owner

SBHg Corporation

Attorney

Michael R. Graham

First Use Date

Aug 24, 1995

Filing Date

Apr 26, 1993

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

HYSEQ Trademark

Serial Number: 74384099 • Registration: 2079490

HYSEQ is a trademark filed by SBHg Corporation on April 26, 1993. The trademark is classified under Class 16 (Paper Goods). The application is currently no longer active.

Owner Contact Info

SBHg Corporation (3 trademarks)

444 N. Michigan Avenue
Chicago, IL 60611

Entity Type: 03

HYSEQ, Inc. (24 trademarks)

670 Almanor Avenue
Sunnyvale, CA 94086

Entity Type: 03

Trademark Details

Filing Date

April 26, 1993

Registration Date

July 15, 1997

First Use Anywhere

August 24, 1995

First Use in Commerce

August 24, 1995

Published for Opposition

April 12, 1994

Cancellation Date

April 17, 2004

Goods & Services

printed matter; namely, informational sheets featuring printed nucleotide sequences

Filing History

CANCELLED SEC. 8 (6-YR)
Apr 17, 2004 C8..
REGISTERED-PRINCIPAL REGISTER
Jul 15, 1997 R.PR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 14, 1997 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Nov 4, 1996 SUPC
USE AMENDMENT FILED
Aug 21, 1996 IUAF
SOU EXTENSION 4 GRANTED
Aug 16, 1996 EX4G
SOU EXTENSION 4 FILED
Jul 5, 1996 EXT4
SOU EXTENSION 3 GRANTED
Mar 6, 1996 EX3G
SOU EXTENSION 3 FILED
Jan 5, 1996 EXT3
SOU EXTENSION 2 GRANTED
Aug 4, 1995 EX2G
SOU EXTENSION 2 FILED
Jun 28, 1995 EXT2
SOU EXTENSION 1 GRANTED
Feb 10, 1995 EX1G
SOU EXTENSION 1 FILED
Jan 5, 1995 EXT1
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jul 5, 1994 NOAM
PUBLISHED FOR OPPOSITION
Apr 12, 1994 PUBO
NOTICE OF PUBLICATION
Mar 11, 1994 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 20, 1993 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 12, 1993 CRFA
NON-FINAL ACTION MAILED
Aug 27, 1993 CNRT
ASSIGNED TO EXAMINER
Aug 5, 1993 DOCK

Related Trademarks

More from this Owner

NUVELO

NUVELO

NUVELO

NUVELO

NUVELO

NUVELO

NUVELO

NUVELO

NUVELO

NUVELO

THE FUTURE OF BIOPHARMACEUTICALS

THE FUTURE OF BIOPHARMACEUTICALS